Formula Growth’s Genesco GCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-14,300
Closed -$562K 136
2022
Q3
$562K Sell
14,300
-5,000
-26% -$267K 0.16% 116
2022
Q2
$963K Sell
19,300
-9,700
-33% -$581K 0.27% 99
2022
Q1
$1.84M Hold
29,000
0.35% 87
2021
Q4
$1.86M Hold
29,000
0.33% 91
2021
Q3
$1.67M Sell
29,000
-7,000
-19% -$416K 0.24% 106
2021
Q2
$2.29M Hold
36,000
0.32% 97
2021
Q1
$1.71M Sell
36,000
-4,000
-10% -$172K 0.25% 115
2020
Q4
$1.2M Buy
40,000
+10,000
+33% +$256K 0.2% 117
2020
Q3
$646K Buy
+30,000
New +$587K 0.12% 136

Other funds holding GCO

Formula Growth's GCO Position: Q4 2022 in Review

Formula Growth sold out of Genesco (GCO) in Q4 2022, closing a stake of 14,300 shares — an estimated $562K sold.

Formula Growth first reported a position in GCO in Q3 2020 and held it in 9 quarters. The position peaked at $2.29M in Q2 2021. 146 funds tracked by Wall St. Rank hold GCO as of Q4 2022.

  • Formula Growth reported no remaining Genesco position as of Q4 2022 after selling out during the quarter.
  • Formula Growth sold 14,300 Genesco shares in Q4 2022, an estimated $562K.
  • Formula Growth first reported a position in Genesco in Q3 2020 and held it in 9 quarters.
  • Formula Growth's Genesco position peaked at $2.29M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Genesco as of Q4 2022.

Based on Formula Growth's 13F filing for Q4 2022, filed 13 Feb 2023.